ArticleJournal of general internal medicine2014
Content analysis of false and misleading claims in television advertising for prescription and nonprescription drugs.
Article in Journal of general internal medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Quality of information in news media reports about the effects of health interventions: Systematic review and meta-analyses.F1000Research · 2021Pooled it
- Teaching Australian high school students to think critically about health claims: a cluster randomized trial.Health education research · 2023Trial
- Navigating the Prescription Drug Information System.Clinical pharmacology and therapeutics · 2026Review
- Multi-stakeholder use of patient experience data (PED): current state and future opportunities for the application of PED to inform decision-making.Journal of patient-reported outcomes · 2026Review
- Quantitative assessment of china's policies on the online sale of prescription drugs.PloS one · 2026Article
- Large Language model (LLM) in temporomandibular disorder education: a comparative study.BMC oral health · 2025Article
- What artificial intelligence (AI) can tell us about Nasoalveolar Molding (NAM)?BMC oral health · 2025Article
- Pharmaceutical Advertising and Public Perceptions in Saudi Arabia.Pharmacy (Basel, Switzerland) · 2024Article
- Assessment of the quality and accuracy of information contained within the websites of marketed orthodontic products: a cross-sectional investigation.The Angle orthodontist · 2024Article
- Fear, misinformation, and pharmaceutical messianism in the promotion of compounded bioidentical hormone therapy.Frontiers in reproductive health · 2024Article
- Detecting and Reporting Deceptive Prescription Drug Promotion: Differences Across Consumer and Physician Audiences and by Number and Type of Deceptive Claims and Tactics.Health communication · 2022Article
- Misleading Advertising of Health-Related Products in Ecuador during the COVID-19 Pandemic.Diseases (Basel, Switzerland) · 2022Article
- The nature and accuracy of Instagram posts concerning marketed orthodontic products.The Angle orthodontist · 2022Article
- Use of High-Dose Influenza and Live Attenuated Influenza Vaccines by US Primary Care Physicians.Journal of general internal medicine · 2021Article
- Toxicity of colloidal silver products and their marketing claims in Finland.Toxicology reports · 2021Article
- Use of over-the-counter laxatives by community-dwelling adults to treat and prevent constipation: a national cross-sectional study.European journal of clinical pharmacology · 2020Article
- The Impact of Direct-to-Consumer Pharmaceutical Advertising on Public Knowledge of Gastroesophageal Reflux Disease: A Study on Over-the-Counter Proton Pump Inhibitors.Patient preference and adherence · 2020Article
- Medicines Information and the Regulation of the Promotion of Pharmaceuticals.Science and engineering ethics · 2019Article
- Communicating Risk Information in Direct-to-Consumer Prescription Drug Television Ads: A Content Analysis.Health communication · 2019Article
- Article
Corrections and comments
- Commented on by
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFalse and misleading advertising for drugs can harm consumers and the healthcare system, and previous research has demonstrated that physician-targeted drug advertisements may be misleading. However, there is a dearth of research comparing consumer-targeted drug advertising to evidence to evaluate whether misleading or false information is being presented in these ads.
objectiveTo compare claims in consumer-targeted television drug advertising to evidence, in order to evaluate the frequency of false or misleading television drug advertising targeted to consumers.
designA content analysis of a cross-section of television advertisements for prescription and nonprescription drugs aired from 2008 through 2010. We analyzed commercial segments containing prescription and nonprescription drug advertisements randomly selected from the Vanderbilt Television News Archive, a census of national news broadcasts. MAIN MEASURES: For each advertisement, the most-emphasized claim in each ad was identified based on claim iteration, mode of communication, duration and placement. This claim was then compared to evidence by trained coders, and categorized as being objectively true, potentially misleading, or false. Potentially misleading claims omitted important information, exaggerated information, made lifestyle associations, or expressed opinions. False claims were factually false or unsubstantiated. KEY
resultsOf the most emphasized claims in prescription (n = 84) and nonprescription (n = 84) drug advertisements, 33 % were objectively true, 57 % were potentially misleading and 10 % were false. In prescription drug ads, there were more objectively true claims (43 %) and fewer false claims (2 %) than in nonprescription drug ads (23 % objectively true, 7 % false). There were similar numbers of potentially misleading claims in prescription (55 %) and nonprescription (61 %) drug ads.
conclusionsPotentially misleading claims are prevalent throughout consumer-targeted prescription and nonprescription drug advertising on television. These results are in conflict with proponents who argue the social value of drug advertising is found in informing consumers about drugs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.